PortfoliosLab logo
APYX vs. GHC
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between APYX and GHC is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

APYX vs. GHC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apyx Medical Corporation (APYX) and Graham Holdings Company (GHC). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

APYX:

-0.03

GHC:

0.96

Sortino Ratio

APYX:

0.80

GHC:

1.61

Omega Ratio

APYX:

1.09

GHC:

1.19

Calmar Ratio

APYX:

-0.01

GHC:

2.05

Martin Ratio

APYX:

-0.05

GHC:

5.10

Ulcer Index

APYX:

27.40%

GHC:

5.85%

Daily Std Dev

APYX:

98.74%

GHC:

30.89%

Max Drawdown

APYX:

-94.99%

GHC:

-67.54%

Current Drawdown

APYX:

-91.03%

GHC:

-4.71%

Fundamentals

Market Cap

APYX:

$63.12M

GHC:

$4.05B

EPS

APYX:

-$0.54

GHC:

$143.34

PS Ratio

APYX:

1.33

GHC:

0.86

PB Ratio

APYX:

5.75

GHC:

0.96

Total Revenue (TTM)

APYX:

$47.29M

GHC:

$4.80B

Gross Profit (TTM)

APYX:

$24.39M

GHC:

$1.42B

EBITDA (TTM)

APYX:

-$14.41M

GHC:

$1.24B

Returns By Period

In the year-to-date period, APYX achieves a -1.27% return, which is significantly lower than GHC's 9.89% return. Over the past 10 years, APYX has underperformed GHC with an annualized return of -5.16%, while GHC has yielded a comparatively higher 5.07% annualized return.


APYX

YTD

-1.27%

1M

50.00%

6M

-3.11%

1Y

-2.50%

3Y*

-36.42%

5Y*

-18.88%

10Y*

-5.16%

GHC

YTD

9.89%

1M

3.73%

6M

2.90%

1Y

29.48%

3Y*

17.05%

5Y*

22.93%

10Y*

5.07%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Apyx Medical Corporation

Graham Holdings Company

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

APYX vs. GHC — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

APYX
The Risk-Adjusted Performance Rank of APYX is 5252
Overall Rank
The Sharpe Ratio Rank of APYX is 4848
Sharpe Ratio Rank
The Sortino Ratio Rank of APYX is 5959
Sortino Ratio Rank
The Omega Ratio Rank of APYX is 5656
Omega Ratio Rank
The Calmar Ratio Rank of APYX is 4949
Calmar Ratio Rank
The Martin Ratio Rank of APYX is 4949
Martin Ratio Rank

GHC
The Risk-Adjusted Performance Rank of GHC is 8282
Overall Rank
The Sharpe Ratio Rank of GHC is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of GHC is 7878
Sortino Ratio Rank
The Omega Ratio Rank of GHC is 7575
Omega Ratio Rank
The Calmar Ratio Rank of GHC is 9393
Calmar Ratio Rank
The Martin Ratio Rank of GHC is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

APYX vs. GHC - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and Graham Holdings Company (GHC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current APYX Sharpe Ratio is -0.03, which is lower than the GHC Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of APYX and GHC, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

APYX vs. GHC - Dividend Comparison

APYX has not paid dividends to shareholders, while GHC's dividend yield for the trailing twelve months is around 0.74%.


TTM20242023202220212020201920182017201620152014
APYX
Apyx Medical Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GHC
Graham Holdings Company
0.74%0.79%0.95%1.05%0.96%1.09%0.87%0.83%0.91%0.95%1.77%1.18%

Drawdowns

APYX vs. GHC - Drawdown Comparison

The maximum APYX drawdown since its inception was -94.99%, which is greater than GHC's maximum drawdown of -67.54%. Use the drawdown chart below to compare losses from any high point for APYX and GHC.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

APYX vs. GHC - Volatility Comparison

Apyx Medical Corporation (APYX) has a higher volatility of 50.96% compared to Graham Holdings Company (GHC) at 5.80%. This indicates that APYX's price experiences larger fluctuations and is considered to be riskier than GHC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

APYX vs. GHC - Financials Comparison

This section allows you to compare key financial metrics between Apyx Medical Corporation and Graham Holdings Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B1.20B20212022202320242025
9.43M
1.17B
(APYX) Total Revenue
(GHC) Total Revenue
Values in USD except per share items

APYX vs. GHC - Profitability Comparison

The chart below illustrates the profitability comparison between Apyx Medical Corporation and Graham Holdings Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20212022202320242025
60.1%
29.7%
(APYX) Gross Margin
(GHC) Gross Margin
APYX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported a gross profit of 5.67M and revenue of 9.43M. Therefore, the gross margin over that period was 60.1%.

GHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a gross profit of 346.56M and revenue of 1.17B. Therefore, the gross margin over that period was 29.7%.

APYX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported an operating income of -3.05M and revenue of 9.43M, resulting in an operating margin of -32.4%.

GHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported an operating income of 47.47M and revenue of 1.17B, resulting in an operating margin of 4.1%.

APYX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apyx Medical Corporation reported a net income of -4.15M and revenue of 9.43M, resulting in a net margin of -44.0%.

GHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Graham Holdings Company reported a net income of 23.89M and revenue of 1.17B, resulting in a net margin of 2.1%.